PAC1 receptor agonist maxadilan alleviates corneal inflammation in a murine model of LPS-induced ocular inflammation

Andras Dobos, Balazs Meresz, Inez Bosnyak, Dorottya Molitor, Bela Kocsis, Edina Szabo, Dora Reglodi, Ildiko Vajda · 2026

Read PAC1 receptor agonist maxadilan alleviates corneal inflammation in a murine model of LPS-induced ocular inflammation by Andras Dobos, Balazs Meresz, Inez Bosnyak, Dorottya Molitor, Bela Kocsis, Edina Szabo, Dora Reglodi, Ildiko Vajda (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0353866.txt.

Description

Andras Dobos and seven colleagues test a hormone-like drug against eye inflammation in mice, in this 2026 PLOS ONE study. The drug, maxadilan, activates a receptor that calms inflammation and swelling, and the team wanted to know whether it could protect the cornea. Mice were given a bacterial toxin that triggers eye inflammation, followed by the drug injected into the eye.

Scans showed less corneal swelling and better-preserved tissue in treated animals. Eye pressure dropped, fewer inflammatory cells gathered in the eye fluid, and several inflammatory signals fell. Microscope checks confirmed the cornea kept its normal structure. The authors propose this receptor as a promising target for treating inflamed eyes.

Catalog record

CREATORAndras Dobos, Balazs Meresz, Inez Bosnyak, Dorottya Molitor, Bela Kocsis, Edina Szabo, Dora Reglodi, Ildiko Vajda
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE46730
LICENSECC_BY
RIGHTSCC BY
SOURCEPLOS

Source: https://doi.org/10.1371/journal.pone.0353866

Browse the full library · About the Tower of Babel